BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 232 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,868,800 | +50.8% | 1,970,000 | +78.6% | 0.23% | +38.5% |
| Q1 2023 | $9,198,094 | +8.9% | 1,102,889 | +5.3% | 0.17% | -54.8% |
| Q4 2018 | $8,449,000 | +5.8% | 1,047,000 | 0.0% | 0.37% | +27.6% |
| Q3 2018 | $7,989,000 | +461.0% | 1,047,000 | +261.0% | 0.29% | +295.9% |
| Q4 2017 | $1,424,000 | -6.3% | 290,000 | 0.0% | 0.07% | -14.0% |
| Q3 2017 | $1,520,000 | -5.7% | 290,000 | 0.0% | 0.09% | -14.0% |
| Q2 2017 | $1,612,000 | – | 290,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,076,924 | 27.82% |
| Prosight Management, LP | 5,000,000 | $35,200,000 | 5.27% |
| Saturn V Capital Management LLC | 954,856 | $6,722,186 | 3.73% |
| ORACLE INVESTMENT MANAGEMENT INC | 555,522 | $3,910,875 | 2.88% |
| Kynam Capital Management, LP | 2,848,197 | $20,051,307 | 2.76% |
| TANG CAPITAL MANAGEMENT LLC | 2,450,000 | $17,248,000 | 2.54% |
| AlphaCentric Advisors LLC | 570,000 | $4,012,800 | 2.23% |
| Eversept Partners, LP | 2,372,113 | $16,699,676 | 1.73% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 760,904 | $5,356,764 | 1.66% |
| Avoro Capital Advisors LLC | 12,055,000 | $84,867,200 | 1.15% |